Single Cell Multiplex Analysis via Nucleic Acid Tag Sequencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for high multiplex analysis of proteins in single cells are limited by spectral overlap in flow cytometry and the number of available isotope tags in mass cytometry, and cannot combine protein detection with DNA readout, necessitating a method for high multiplex analysis of cellular constituents in single cells.

Innovation Solution

A method involving the use of nucleic acid tags linked to existing ligand binding and/or antibody technologies for proteomic or cellular constituent detection and relative quantification by next-generation sequencing (NGS), where cellular constituents are embedded in polymer matrices, labeled with oligonucleotide tags, and sequenced to identify and quantify cellular components.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If flow cytometry is used for protein detection, then single cell analysis is enabled, but spectral overlap limits the number of proteins that can be detected simultaneously

Engineering Contradiction:
Improvenumber of proteins detectedVSAvoidspectral overlap
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The patent replaces the optical detection system of flow cytometry with a sequencing-based detection system. Instead of using fluorescent tags that suffer from spectral overlap, the invention uses oligonucleotide tags that are detected through next-generation sequencing, eliminating the spectral overlap problem while enabling detection of many more proteins simultaneously

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces oligonucleotide tags as intermediaries between proteins and detection. These tags are attached to proteins via antibodies or other binding molecules, and the tags themselves are sequenced rather than directly detecting the proteins, allowing for high multiplexing without spectral interference

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If mass cytometry is used for protein detection, then isotope tags enable multiplexed detection, but the number of available isotope tags limits the analysis capacity

Engineering Contradiction:
Improvenumber of proteins detectedVSAvoidnumber of isotope tags
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent changes the detection parameter from mass-to-charge ratio (in mass cytometry) to nucleotide sequence. This allows using the vast diversity of oligonucleotide sequences instead of the limited number of isotope tags, enabling detection of hundreds or thousands of proteins simultaneously without increasing physical device complexity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent transitions from detecting proteins in the mass spectrum dimension to detecting them in the sequence space dimension. By encoding protein identity in oligonucleotide sequences rather than mass tags, the system achieves much higher multiplexing capacity

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Adaptability or versatility

If conventional methods are used, then protein detection is possible, but combining protein detection with DNA readout in single cells is not achievable

Engineering Contradiction:
Improveintegration of protein and DNA analysisVSAvoidmultiplex analysis capacity
Core Design Contradiction:
Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

The patent merges protein detection and DNA analysis into a single unified workflow. By using oligonucleotide tags that can be co-sequenced with genomic DNA from the same single cell, the method simultaneously provides protein expression profiles and genomic information without requiring separate experiments

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The oligonucleotide tag system serves multiple functions: it identifies proteins through sequencing, enables quantification of protein abundance, and can be integrated with genomic DNA analysis from the same cell, creating a universal platform for multi-omics analysis

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables high multiplex analysis of proteins and cellular constituents in single cells, allowing for comparison of protein data variation between cells and different biological conditions, and provides massively parallel profiling of circuit aspects from RNA to chromatin organization.

Implementation Method 1

admixing at least one isolated aggregation of cellular constituents with monomers of a polymerizable gel; polymerizing the gel, to embed the cellular constituents in discrete polymer matrices

Methodology Applied
Scientific EffectPolymerization: Photopolymerisation

Implementation Method 2

incubating the cellular constituents embedded in the polymer matrices with one or more labeling ligands with specific binding affinity for one or more target cellular constituents

Methodology Applied
Scientific EffectSpecific binding: Adsorption

Implementation Method 3

sequencing the oligonucleotide label, whereby detecting the UCI by sequencing indicates the presence of the target cellular constituent

Methodology Applied
Scientific EffectDNA sequencing:

Data Source

PatentUS11092607B2Multiplex analysis of single cell constituents
Publication Date: 2021.08.17 THE BROAD INST INC
  • US11092607B2 patent drawing
  • US11092607B2 patent drawing
  • US11092607B2 patent drawing

AI summary

The present invention relates to methods for high multiplex protein or cellular constituent analysis in single cells or single isolated aggregations of cellular constituents. The methods provide for embedding cells or isolated aggregations of cellular constituents in a hydrogel mesh and labeling of cellular constituents with labeling ligands linked to a nucleic acid tag. Cellular constituents can be determined using sequencing methods.